A Targeted Cancer Treatment using Nanomaterials
August 27, 2009
Thousands of people die from malignant brain tumors every year, and the tumors are resistant to conventional therapies. Now, scientists from the Center for Nanoscale Materials, Advanced Photon Source, and Chemical Sciences and Engineering Division at the U.S. Department of Energy's Argonne National Laboratory; and the University of Chicago's Brain Tumor Center have developed a way to target brain cancer cells that may eventually provide an alternative form of therapy that does not affect normal living tissue.